Performance-enhancing supplement claims in combat sports drive both athlete demand and regulatory scrutiny. This trial tests whether CBD—increasingly used off-label for recovery and anxiety in high-contact athletics—has measurable effects on injury incidence, performance metrics, or stress markers in a sport where both CNS effects and anti-inflammatory properties would theoretically matter.
This is an active clinical trial (NCT07552974) investigating CBD supplementation in Brazilian Jiu-Jitsu athletes, likely examining effects on injury prevention, recovery, anxiety, or performance outcomes. The rationale likely centers on CBD’s putative anti-inflammatory and anxiolytic properties, and its legal status as a non-prohibited supplement in most sports governing bodies. The trial design, enrollment size, dosing regimen, and primary endpoints are not detailed in the available summary, so conclusions about methodology strength or clinical relevance require access to the full protocol.
“*We need to see the actual data before we know if this moves the needle.* CBD in athletes is a plausible hypothesis—inflammation and anxiety are real in combat sports—but the evidence base for performance or injury outcomes in this population remains thin. The trial is the right move; anecdotal enthusiasm from athletes is not.”
💬 Join the Conversation
This topic comes up in consultations often.
Dr. Caplan offers clinical context on evolving cannabis policy and its real-world implications for patients.
Book a consultation →Have a question about how this applies to your situation? Ask Dr. Caplan →
Want to discuss this topic with other patients and caregivers? Join the forum discussion →
Have thoughts on this? Share it:
Table of Contents
FAQ
What is CED Clinical Relevance #60?
This is a notable clinical interest alert highlighting emerging findings or policy developments in cannabis and cannabinoid research worth monitoring closely. It represents the latest update in the CED Clinic’s series of clinical relevance reports.
What topics are covered in this article?
The article focuses on cannabis news related to performance and recovery, CBD, anti-inflammatory effects, athletic medicine, and evidence that is currently in progress. These topics represent key areas of clinical interest in cannabinoid research.
What is CBD and how does it relate to this article?
CBD (cannabidiol) is a non-intoxicating compound from cannabis highlighted as a subject of clinical interest. The article examines its potential anti-inflammatory properties and applications in athletic medicine and performance recovery.
Why is this marked as “Evidence in Progress”?
This tag indicates that the clinical evidence surrounding these cannabis-related topics is still being developed and researched. It suggests that while findings are emerging, more studies are needed to establish definitive clinical applications.
What should clinicians do with this information?
Clinicians should monitor this emerging research on cannabis and CBD for potential clinical applications in their practice, particularly regarding anti-inflammatory effects and athletic medicine. The findings are important to track as evidence continues to develop.
